Ovid Therapeutics Inc. (OVID) Ownership

$0.98

south_east -$0.02 (-2.33%)
Day's range
$0.97
Day's range
$1.04

Ovid Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RUBRIC CAPITAL MANAGEMENT LP 11/13/2024 5.32 M $6.27 M   0.00% 7.49%
BLACKROCK FUNDING, INC. /DE 11/13/2024 4.31 M $5.09 M   100.00% 6.08%
MADISON AVENUE PARTNERS, LP 11/14/2024 4.12 M $4.86 M   0.85% 5.80%
BVF INC/IL 11/14/2024 3.85 M $4.55 M   0.00% 5.43%
VANGUARD GROUP INC 11/13/2024 3.14 M $3.71 M   1.72% 4.43%
SIREN, L.L.C. 11/13/2024 2.85 M $3.36 B   100.00% 4.02%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 1.85 M $2.18 M   10.98% 2.60%
KENNEDY CAPITAL MANAGEMENT LLC 11/14/2024 1.53 M $1.80 M   2.65% 2.15%
JPMORGAN CHASE & CO 12/26/2024 1.46 M $1.73 M   -0.18% 2.06%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2024 1.40 M $1.65 M   0.00% 1.97%
STATE STREET CORP 11/14/2024 1.36 M $1.61 M   0.52% 1.92%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.32 M $1.55 M   1.14% 1.86%
TLS ADVISORS LLC 11/12/2024 771,531 $910,000   -31.44% 1.09%
WELLS FARGO & COMPANY/MN 11/13/2024 735,185 $867,518   -0.87% 1.04%
PROSIGHT MANAGEMENT, LP 11/14/2024 729,208 $860,465   -32.17% 1.03%
UBS OCONNOR LLC 11/14/2024 628,290 $741,382   117.94% 0.89%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2024 309,540 $365,257   -12.10% 0.44%
GSA CAPITAL PARTNERS LLP 11/05/2024 260,509 $307,000   117.99% 0.37%
MORGAN STANLEY 11/14/2024 165,830 $195,679   140.51% 0.23%
BANK OF NEW YORK MELLON CORP 11/12/2024 165,763 $195,600   -24.02% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 161,808 $190,933   0.00% 0.23%
EMPOWERED FUNDS, LLC 11/06/2024 145,340 $171,501   5.34% 0.20%
GOLDMAN SACHS GROUP INC 11/14/2024 130,279 $153,729   2.72% 0.18%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 119,113 $140,553   0.00% 0.17%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 104,011 $122,733   -62.18% 0.15%
ASSENAGON ASSET MANAGEMENT S.A. 10/23/2024 86,289 $101,821   100.00% 0.12%
BARCLAYS PLC 11/19/2024 84,175 $98,000   311.15% 0.12%
VERITION FUND MANAGEMENT LLC 11/14/2024 74,875 $88,353   100.00% 0.11%
RHUMBLINE ADVISERS 11/12/2024 68,723 $81,088   -1.45% 0.10%
FMR LLC 11/13/2024 50,225 $59,265   1,907.39% 0.07%
ALLIANCEBERNSTEIN L.P. 11/14/2024 47,880 $56,498   0.00% 0.07%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 44,500 $52,510   -68.48% 0.06%
JANE STREET GROUP, LLC 11/15/2024 38,399 $45,311   -61.05% 0.05%
XTX TOPCO LTD 11/14/2024 38,230 $45,111   46.17% 0.05%
BANK OF AMERICA CORP /DE/ 11/14/2024 37,892 $44,712   28.30% 0.05%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2024 37,743 $44,537   96.68% 0.05%
CITADEL ADVISORS LLC 11/14/2024 37,400 $44,132   263.11% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2024 34,086 $40,221   10.26% 0.05%
BLAIR WILLIAM & CO/IL 11/12/2024 32,039 $37,806   3.22% 0.05%
COREBRIDGE FINANCIAL, INC. 11/13/2024 31,489 $37,157   -0.61% 0.04%
UBS GROUP AG 11/14/2024 30,612 $36,122   44.45% 0.04%
INVESCO LTD. 11/12/2024 29,337 $34,618   1.69% 0.04%
TEJARA CAPITAL LTD 11/13/2024 29,329 $34,608   -57.19% 0.04%
FIRST MANHATTAN CO. LLC. 11/14/2024 26,000 $30,680   0.00% 0.04%
SG AMERICAS SECURITIES, LLC 10/03/2024 20,464 $24,000   100.00% 0.03%
NEW YORK STATE COMMON RETIREMENT FUND 10/28/2024 18,986 $22,000   0.00% 0.03%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 17,396 $21,000   0.00% 0.02%
NEWMAN DIGNAN & SHEERAR, INC. 11/12/2024 16,522 $19,331   100.00% 0.02%
DCF ADVISERS, LLC 11/13/2024 14,750 $17,405   -64.67% 0.02%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 10/25/2024 13,650 $16,107   63.77% 0.02%

Ovid Therapeutics Inc.institutional Ownership - FAQ's

Who are the largest shareholders of OVID shares?

During the previous two years, 89 institutional investors and hedge funds held shares of Ovid Therapeutics Inc.. The most heavily invested institutionals were:

Rubric Capital Management LP: 5.32 M

BlackRock Funding, Inc. /DE: 4.31 M

Madison Avenue Partners, LP: 4.12 M

BVF INC/IL: 3.85 M

VANGUARD GROUP INC: 3.14 M

Siren, L.L.C.: 2.85 M

What percentage of Ovid Therapeutics Inc. stock is owned by institutional investors?

54.66% of Ovid Therapeutics Inc. stock is owned by institutional investors.

How much institutional buying is happening at OVID ?

Institutional investors have bought a total of 44.00 M shares in the last 24 months. This purchase volume represents approximately $43.12 M in transactions.